The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1592
February 24, 2020
View Complete Issue         Table of Contents 2019 
Drugs for Depression

This article is no longer freely available.

Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Drugs for Depression
February 24, 2020 (Issue: 1592)
Complete remission of symptoms is the goal of treatment for major depressive disorder; a partial response is associated with an increased risk of relapse. Improvement in symptoms can occur within the first two weeks of treatment with an...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Drugs for Depression
Article code: 1592a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.